Rumiana Bakalova

Prof. Dr. Rumiana Bakalova

1. Department of Molecular Imaging and Theranostics, National Institutes for Quantum Science and Technology (QST), Chiba 263-8555, Japan
+1

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Redox Biology
Verified
Journal Article
Open access
DIDonika Ivanova
Donika Ivanova
ZZZhivko Zhelev
Zhivko Zhelev
PGPlamen Getsov
Plamen Getsov
BNBiliana Nikolova
Biliana Nikolova
IAIchio Aoki
Ichio Aoki
RBRumiana Bakalova
Rumiana Bakalova
This review is directed to the redox-modulating properties and anticancer effect of vitamin K. The concept is focused on two aspects: (i) redox-cycle of vitamin K and its effect on the calcium homeostasis, "oncogenic" and "onco-suppressive" reactive oxygen species and the specific induction of oxidative stress in cancer; (ii) vitamin K plus C as a powerful redox-system, which forms a bypass between mitochondrial complexes II and III and thus prevents mitochondrial dysfunction, restores oxidative phosphorylation and aerobic glycolysis, modulates the redox-state of endogenous redox-pairs, eliminates the hypoxic environment of cancer cells and induces cell death. The analyzed data suggest that vitamin C&K can sensitize cancer cells to conventional chemotherapy, which allows achievement of a lower effective dose of the drug and minimizing the harmful side-effects. The review is intended for a wide audience of readers - from students to specialists in the field.

1 January 2016 in Chinese Journal of Cancer Research
Verified
Journal Article
Open access
DIDonika Ivanova
Donika Ivanova
ZZZhivko Zhelev
Zhivko Zhelev
IAIchio Aoki
Ichio Aoki
RBRumiana Bakalova
Rumiana Bakalova
THTatsuya Higashi
Tatsuya Higashi
Many studies demonstrate that conventional anticancer drugs elevate intracellular level of reactive oxygen species (ROS) and alter redox-homeostasis of cancer cells. It is widely accepted that anticancer effect of these chemotherapeutics is due to induction of oxidative stress and ROS-mediated apoptosis in cancer. On the other hand, the harmful side effects of conventional anticancer chemotherapy are also due to increased production of ROS and disruption of redox-homeostasis of normal cells and tissues. This article describes the mechanisms for triggering and modulation of apoptosis through ROS-dependent and ROS-independent pathways. We try to answer the question: "Is it possible to induce highly specific apoptosis only in cancer cells, without overproduction of ROS, as well as without harmful effects on normal cells and tissues?" The review also suggests a new therapeutic strategy for selective killing of cancer cells, without significant impact on viability of normal cells and tissues, by combining anticancer drugs with redox-modulators, affecting specific signaling pathways and avoiding oxidative stress.

3 October 2017 in Anticancer Research
Verified
Journal Article
Open access
PDF file
Ekaterina GeorgievaEkaterina Georgieva
Ekaterina Georgieva
DIDonika Ivanova
Donika Ivanova
ZZZhivko Zhelev
Zhivko Zhelev
RBRumiana Bakalova
Rumiana Bakalova
MGMaya Gulubova
Maya Gulubova
IAIchio Aoki
Ichio Aoki
The intracellular redox balance (redox status) is a dynamic system that may change via many factors. Mitochondria are one of the most important among them. These organelles are the main intracellular source of energy. They are essential for maintaining cellular homeostasis due to regulation of many biochemical processes. The mitochondrial dynamics change during cellular activities and in some cases, can cause an overproduction of reactive oxygen species (ROS), which encourages the induction of oxidative DNA damage and up- or down-regulation of phosphatases, proliferative/anti-proliferative factors, apoptotic/anti-apoptotic factors, etc. Moreover, mitochondrial dysfunction and redox imbalance can continuously support and contribute to a wide range of pathologies, termed as “free radical diseases” (e.g., cancer, neurodegeneration, atherosclerosis, inflammation, etc.). This review article is focused on the mitochondrial dysfunction and cellular redox status as a hallmark of cell homeostasis and diagnostic marker of cancer. It is intended to broad readership – from students to specialists in the field.

11 September 2013 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
ZZZhivko Zhelev
Zhivko Zhelev
RBRumiana Bakalova
Rumiana Bakalova
IAIchio Aoki
Ichio Aoki
DLDessislava Lazarova
Dessislava Lazarova
TSTsuneo Saga
Tsuneo Saga

22 May 2008 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
RBRumiana Bakalova
Rumiana Bakalova
ZZZhivko Zhelev
Zhivko Zhelev
IAIchio Aoki
Ichio Aoki
KMKazuto Masamoto
Kazuto Masamoto
MMMilka Mileva
Milka Mileva
IKIwao Kanno
Iwao Kanno

30 April 2013 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
RBRumiana Bakalova
Rumiana Bakalova
ZZZhivko Zhelev
Zhivko Zhelev
IAIchio Aoki
Ichio Aoki
TSTsuneo Saga
Tsuneo Saga
Purpose: The study aimed to clarify the dynamics of tissue redox activity (TRA) in cancer progression and assess the importance of this parameter for therapeutic strategies. Experimental Design: The experiments were carried out on brain tissues of neuroblastoma-bearing, glioma-bearing, and healthy mice. TRA was visualized in vivo by nitroxide-enhanced MRI on anesthetized animals or in vitro by electron paramagnetic resonance spectroscopy on isolated tissue specimens. Two biochemical parameters were analyzed in parallel: tissue total antioxidant capacity (TTAC) and plasma levels of matrix metalloproteinases (MMP). Results: In the early stage of cancer, the brain tissues were characterized by a shorter-lived MRI signal than that from healthy brains (indicating a higher reducing activity for the nitroxide radical), which was accompanied by an enhancement of TTAC and MMP9 plasma levels. In the terminal stage of cancer, tissues in both hemispheres were characterized by a longer-lived MRI signal than in healthy brains (indicating a high-oxidative activity) that was accompanied by a decrease in TTAC and an increase in the MMP2/MMP9 plasma levels. Cancer progression also affected the redox potential of tissues distant from the primary tumor locus (liver and lung). Their oxidative status increased in both stages of cancer. Conclusions: The study shows that tissue redox balance is very sensitive to the progression of cancer and can be used as a diagnostic marker of carcinogenesis. The study also suggests that the noncancerous tissues of a cancer-bearing organism are susceptible to oxidative damage and should be considered a therapeutic target. Clin Cancer Res; 19(9); 2503–17. ©2013 AACR.